Does EVOLOCUMAB Cause Therapy interrupted? 646 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 646 reports of Therapy interrupted have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.4% of all adverse event reports for EVOLOCUMAB.
646
Reports of Therapy interrupted with EVOLOCUMAB
0.4%
of all EVOLOCUMAB reports
3
Deaths
181
Hospitalizations
How Dangerous Is Therapy interrupted From EVOLOCUMAB?
Of the 646 reports, 3 (0.5%) resulted in death, 181 (28.0%) required hospitalization, and 2 (0.3%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 646 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which EVOLOCUMAB Alternatives Have Lower Therapy interrupted Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE